Lurasidone: all 66 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Broadband Near Infrared Spectroscopy to Understand the Role of Brain Cytochrome C Oxidase in Bipolar DisorderNot yet recruitingNCT07806227Phase 4
• Study of Lurasidone as Adjunctive Treatment in Patients With Major Depressive Disorder With Inadequate Response to Antidepressant MonotherapyNot yet recruitingNCT07781293Phase 3
• NRX-101 for Complicated Urinary Tract Infection (UTI) Including PyelonephritisNot yet recruitingNCT06128213Phase 2
• Chinese Longitudinal and Systematic Study of Bioplar DisorderRecruitingNCT05480150Not applicable
• 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar DisorderCompletedNCT03902613Phase 4Results posted
• A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With SchizophreniaCompletedNCT03627195Phase 1Results posted
• Biosignatures of Latuda for Bipolar DepressionCompletedNCT02239094Not applicableResults posted
• Lurasidone Effects on Tissue Glutamate in SchizophreniaCompletedNCT02199743Phase 4Results posted
• Pharmacokinetic Study of Lurasidone After Multiple Oral Administration in Healthy Human SubjectsCompletedNCT02174523Phase 1Results posted
• A Pharmacokinetic Study of Lurasidone After Single Oral Administration in Healthy SubjectsCompletedNCT02174510Phase 1Results posted
• Lurasidone Pediatric Bipolar StudyCompletedNCT02046369Phase 3Results posted
• A Clinical Trial of Lurasidone in Treatment of SchizophreniaCompletedNCT02002832Phase 3Results posted
• A Long-Term Study of SM-13496 in Patients With Bipolar I Disorder.CompletedNCT01986114Phase 3Results posted
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.CompletedNCT01986101Phase 3Results posted
• Pediatric Open-Label Extension StudyCompletedNCT01914393Phase 3Results posted
• Lurasidone Pediatric Autism StudyCompletedNCT01911442Phase 3Results posted
• Pediatric Schizophrenia Efficacy and Safety StudyCompletedNCT01911429Phase 3Results posted
• Lurasidone Low-Dose - High-Dose Study StudyCompletedNCT01821378Phase 3Results posted
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and AdolescentsCompletedNCT01731119Phase 2Results posted
• Lurasidone Pediatric Pharmacokinetics StudyCompletedNCT01620060Phase 1Results posted
• Long-term Extension Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614912Phase 3Results posted
• A Phase III Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT01614899Phase 3Results posted
• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296CompletedNCT01575561Phase 3Results posted
• High Dose Lurasidone for Patients With Treatment Resistant SchizophreniaCompletedNCT01569659Phase 4Results posted
• A Twelve Week, Open Label Extension Study in Patients With SchizophreniaCompletedNCT01566162Phase 3Results posted
• Lurasidone Extended Use StudyCompletedNCT01485640Phase 3Results posted
• PEARL Schizophrenia MaintenanceCompletedNCT01435928Phase 3Results posted
• Major Depressive Disorder With Mixed Features - ExtensionCompletedNCT01423253Phase 3Results posted
• Major Depressive Disorder (MDD) With Mixed Features - Flexible DoseCompletedNCT01421134Phase 3Results posted
• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or DivalproexCompletedNCT01358357Phase 3Results posted
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I DepressionCompletedNCT01284517Phase 3Results posted
• A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective DisorderCompletedNCT01143090Phase 3Results posted
• A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic AgentsCompletedNCT01143077Phase 3Results posted
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I DepressionCompletedNCT00868959Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)CompletedNCT00868699Phase 3Results posted
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)CompletedNCT00868452Phase 3Results posted
• Lurasidone HCL - A 6-week Phase 3 Study of Patients With Acute Schizophrenia.CompletedNCT00790192Phase 3Results posted
• Study of SM-13496 (Lurasidone HCl) in Patients With SchizophreniaCompletedNCT00711269Phase 3Results posted
• Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable SchizophreniaCompletedNCT00641745Phase 3Results posted
• Lurasidone HCl A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00615433Phase 3Results posted
• Lurasidone HCl: A Phase 3 Study of Patients With Acute SchizophreniaCompletedNCT00549718Phase 3Results posted
• A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of SchizophreniaCompletedNCT00088634Phase 2Results posted
• A Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaCompletedNCT00088621Phase 2Results posted
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaCompletedNCT00044044Phase 2Results posted
• Safety and Tolerability Study of Drug to Treat SchizophreniaCompletedNCT00044005Phase 2Results posted
• Sequential Multiple Assignment Randomized Trial for Bipolar DepressionActive, not recruitingNCT06433635Phase 4
• Impact of Structural and Myelin Abnormalities on Cognitive Impairments in Recent-onset Schizophrenia - Before and After Lurasidone Treatment (MARYLU)Status unknownNCT05351736Phase 4
• The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From OlanzapineTerminatedNCT05213143Phase 4
• The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With SchizophreniaCompletedNCT05011669Phase 4
• A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I DepressionTerminatedNCT04383691Phase 3
• A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With SchizophreniaCompletedNCT03465787Phase 3
• A Study of Lurasidone HCl in Subjects With SchizophreniaCompletedNCT03393026Phase 4
• Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated SchizophreniaCompletedNCT03304457Phase 4
• Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar PatientsCompletedNCT02731612Phase 3
• Lurasidone and Cognition in Bipolar I DisorderCompletedNCT02147379Phase 3
• A D2 Receptor Occupancy and fMRI Study in Schizophrenic Subjects Treated With LurasidoneCompletedNCT01979679Phase 3
• Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years OldWithdrawnNCT01932541Phase 4
• Major Depressive Disorder With Mixed FeaturesWithdrawnNCT01423240Phase 3
• Digoxin Drug-Drug Interaction With Lurasidone HClCompletedNCT01082289Phase 1
• Rifampin Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082276Phase 1
• Midazolam Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01082263Phase 1
• The Bioequivalence Of Two Different Lurasidone Formulations In PatientsCompletedNCT01082250Phase 1
• RI-AME Study OF [ISOTHIAZOLYL-3-14C]-LURASIDONECompletedNCT01082146Phase 1
• Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HClCompletedNCT01074632Phase 1
• Lithium Drug-Drug Interaction Study With Lurasidone HClCompletedNCT01074073Phase 1
• A Randomized, Placebo-Controlled, Two-Period, Crossover Study to Evaluate the Effect of Lurasidone HCl on Oral Contraceptive Pharmacokinetics in Healthy Female SubjectsCompletedNCT00549666Phase 1

← Lurasidone overview